PAR
Click for more information
1.67% 30.5¢ paradigm biopharmaceuticals limited..

Richard Coppleson, Bell Potter Securities. Subscription. Don't...

  1. Lucretious
    5,852 Posts.
    lightbulb Created with Sketch. 1798
    clock Created with Sketch.
    20/04/22
    13:45
    Post #: 60936815
    Richard Coppleson, Bell Potter Securities. Subscription. Don't have one. Accumulating since FDA Fast Track approval
    PAR Price at posting: $1.46 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy to raise $1.21M to explore 'newsy' WA targets
right-arrow Created with Sketch.
IVR Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage
right-arrow Created with Sketch.
NEWS Bitcoin investors need to know the risks
right-arrow Created with Sketch.
MEU Marmota hopes to punch through the ceiling of a high-grade system at Goolagong – geology willing
right-arrow Created with Sketch.
RIO Rio registers 2% drop in iron ore production in 2nd quarter of 2024
right-arrow Created with Sketch.
NEWS Almonty locks in govt agreement for tungsten oxide plant in South Korea
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.5¢ 		Change
0.005(1.67%) 		Mkt cap ! $104.9M
Open High Low Value Volume
30.5¢ 30.5¢ 29.5¢ $51.07K 170.4K

Buyers (Bids)

No. Vol. Price($)
5 33007 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 105120 8
View Market Depth
Last trade - 11.20am 17/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.